Skip to content
Open access

Tuning of physicochemical and photocatalytic properties of dual-phase TiO2: Rare earth mono-doping versus co-doping

Sep 2026 · Chemical Engineering and Science · 0 citations · 101 references

Abstract

Modification of TiO 2 with rare-earth elements is an effective approach to improve photocatalytic efficiency and extend photoactivity into the visible region. Dual-phase anatase-brookite TiO 2 mono-doped with Sm, Gd, Tb, Tm, or Yb, and co-doped with SmGd, SmTb, SmTm, or SmYb, were prepared by a template-free one-step hydro-thermal method, and the effects of mono-versus co-doping on the morphological, structural, textural, optical, and photocatalytic properties of the materials were systematically compared. X-ray diffraction, Raman, Fourier-transform infrared, and high-resolution transmission electron microscopy confirmed that the dual-phase anatase-brookite structure is preserved after doping. The formation of mesoporous materials with developed porosity was proven by nitrogen physisorption. It was established that mono-doping favours the formation of powders with increased surface area, while co-doping supports the formation of larger pores. Ultraviolet – visible diffuse reflectance spectroscopy and photoluminescence spectroscopy demonstrated enhanced visible-light absorption and suppressed charge recombination for the doped powders, with stronger effect for co-doped materials due to the synergistic contribution of coupled dopants ’ energy levels. The photocatalytic performance was evaluated in the degradation of a commercial diclofenac drug under UV and visible-light illumination. In the tests, the most active catalyst was TiO 2 co-doped with Sm and Gd, which reached the drug removal rates of 20.4 % and 79.9 % under visible ( > 450 nm) and ultraviolet light, respectively. These results provide new insight into the structure – property – activity relationships of mono-and co-doped REE anatase-brookite TiO 2 composition and will aid the optimal design and fabrication of photocatalysts for pharmaceutical waste decomposition in aquatic environments.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.